---
title: ProSciento vs Proxima Clinical Research
slug_a: prosciento
slug_b: proximacro
site: cro
review_signal_gate: closed
canonical_path: /compare/prosciento/proximacro
generated_by: BioBM Editorial AI
---

# ProSciento vs Proxima Clinical Research

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

ProSciento (prosciento) is listed for cro. Specialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.

Services: 5. Modalities: 0. Indications: 3. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Proxima Clinical Research (proximacro) is listed for cro. Proxima Clinical Research provides integrated regulatory, clinical, and quality solutions for life science companies, with expertise across device and therapeutic development pathways including IDE, 510(k), IND, NDA, and BLA submissions.

Services: 8. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.